EUVIMEDEUVIMED entdecken
Crossref

Ex Vivo Drug Screening Assay with Artificial Membranes: Characterizing Cholesterol Desorbing Competencies of Beta-Cyclodextrins

Jacob K Al-Husseini iD, Ethan M Fong, Chris Wang, Joseph H Ha, Meenakshi Upreti, Peter A Chiarelli, Malkiat S Johal iD

Langmuir · 2023

DOI: 10.1021/acs.langmuir.3c01173 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Langmuir, 2023. Verfasst von Jacob K Al-Husseini und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, Children's Hospital Los Angeles, Los Angeles, California 90027, United States. Hauptthemen laut MEDLINE: beta-Cyclodextrins, Cyclodextrins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Alternatives Research and Development Foundation, Pomona College, Arnold and Mabel Beckman Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite advancements in contemporary therapies, cardiovascular disease from atherosclerosis remains a leading cause of mortality worldwide. Supported lipid bilayers (SLBs) are membrane interfaces that can be constructed with varying lipid compositions. Herein, we use a solvent-assisted lipid bilayer (SALB) construction method to build SLB membranes with varying cholesterol compositions to create a lipid-sterol interface atop a piezoelectric sensor. These cholesterol-laden SLBs were utilized to investigate the mechanisms of various cholesterol-lowering drug molecules. Within a flow-cell, membranes with varying cholesterol content were exposed to cyclodextrins 2-hydroxypropyl-beta-cyclodextrin (HPβCD) and methyl-beta-cyclodextrin (MβCD). Quartz-crystal microgravimetry with dissipation monitoring (QCM-D) enabled the collection of in vitro, real-time changes in relative areal mass and dissipation. We define the cholesterol desorbing competency of a cyclodextrin species via measures of the rate of cholesterol removal, the rate of the transfer of membrane-bound cholesterol to drug-complexed cholesterol, and the binding strength of the drug to the cholesterol-ladened membrane. Desorption data revealed distinct cholesterol removal kinetics for each cyclodextrin while also supporting a model for the lipid-cholesterol-drug interface. We report that MβCD removes a quantity of cholesterol 1.61 times greater, with a speed 2.12 times greater, binding affinity to DOPC lipid interfaces 1.97 times greater, and rate of internal cholesterol transfer 3.41 times greater than HPβCD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-CyclodextrinsCyclodextrinsMembranes, Artificial2-Hydroxypropyl-beta-cyclodextrinDrug Evaluation, PreclinicalLipid BilayersCholesterol

Substanzen

Membranes, Artificial2-Hydroxypropyl-beta-cyclodextrinbeta-CyclodextrinsLipid BilayersCholesterolCyclodextrins

Autor:innen und Institutionen

  • Department of Neurological Surgery, Children's Hospital Los Angeles, Los Angeles, California 90027, United States.
  • The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California 90027, United States.
  • Department of Chemistry, Pomona College, Claremont, California 91711, United States.

ORCID-Profile: Jacob K Al-Husseini, Malkiat S Johal

Förderung

  • Alternatives Research and Development Foundation
  • Pomona College
  • Arnold and Mabel Beckman Foundation
  • Children's Cancer Research Fund

Zitieren

APA

Al-Husseini, J. K., Fong, E. M., Wang, C., Ha, J. H., Upreti, M., Chiarelli, P. A., & Johal, M. S. (2023). Ex Vivo Drug Screening Assay with Artificial Membranes: Characterizing Cholesterol Desorbing Competencies of Beta-Cyclodextrins. Langmuir. https://doi.org/10.1021/acs.langmuir.3c01173

Vancouver

Al-Husseini JK, Fong EM, Wang C, Ha JH, Upreti M, Chiarelli PA, et al. Ex Vivo Drug Screening Assay with Artificial Membranes: Characterizing Cholesterol Desorbing Competencies of Beta-Cyclodextrins. Langmuir. 2023. doi:10.1021/acs.langmuir.3c01173

BibTeX
@article{AlHusseini2023,
  author = {Al-Husseini, Jacob K and Fong, Ethan M and Wang, Chris and Ha, Joseph H and Upreti, Meenakshi and Chiarelli, Peter A and Johal, Malkiat S},
  title = {Ex Vivo Drug Screening Assay with Artificial Membranes: Characterizing Cholesterol Desorbing Competencies of Beta-Cyclodextrins},
  journal = {Langmuir},
  year = {2023},
  doi = {10.1021/acs.langmuir.3c01173}
}
Kostenlos starten →